The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.

The exonuclease1 (Exo1) gene is a key component of mismatch repair (MMR) by resecting the damaged strand, which is the only exonuclease involved in the human MMR system. The gene product is a member of the RAD2 nuclease family and functions in DNA replication, repair and recombination. However, whet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fujiao Duan, Chunhua Song, Liping Dai, Shuli Cui, Xiaoqin Zhang, Xia Zhao
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/90c8213267b94292bea3d959ccd6721c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:90c8213267b94292bea3d959ccd6721c
record_format dspace
spelling oai:doaj.org-article:90c8213267b94292bea3d959ccd6721c2021-11-18T08:20:10ZThe significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.1932-620310.1371/journal.pone.0096764https://doaj.org/article/90c8213267b94292bea3d959ccd6721c2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24810280/?tool=EBIhttps://doaj.org/toc/1932-6203The exonuclease1 (Exo1) gene is a key component of mismatch repair (MMR) by resecting the damaged strand, which is the only exonuclease involved in the human MMR system. The gene product is a member of the RAD2 nuclease family and functions in DNA replication, repair and recombination. However, whether Exo1 is required to activate MMR-dependent DNA damage response (DDR) remains unknown, the conclusions of the Exo1 polymorphisms on cancer susceptibility studies were not consistent. We carried out a meta-analysis of 7 case-control studies to clarify the association between the Exo1 K589E polymorphism and cancer risk. Overall,a significant association of the Exo1 K589E polymorphism with cancer risk in all genetic models (Lys vs Glu: OR = 1.51, 95%CI:1.39-1.99, P<0.01; Glu/Lys vs Glu/Glu: OR = 1.43, 95%CI:1.28-1.60, P<0.01; Lys/Lys vs Glu/Glu: OR = 2.45, 95%CI:1.90-3.17, P<0.01; Lys/Lys+Glu/Lys vs Glu/Glu: OR = 1.53, 95%CI:1.38-1.71, P<0.01; Glu/Glu vs Glu/Lys+Lys/Lys: OR =  2.27, 95%CI:1.79-2.89, P<0.01). In the stratified analysis by ethnicity, significantly increased risk was observed in Asian population (Lys vs Glu: OR = 1.53, 95%CI:1.39-1.69, P<0.01; Glu/Lys vs Glu/Glu: OR = 1.50, 95%CI:1.34-1.69, P<0.01; Lys/Lys vs Glu/Glu: OR = 2.48, 95%CI:1.84-3.34, P<0.01; Lys/Lys+Glu/Lys vs Glu/Glu: OR = 1.58, 95%CI:1.41-1.78, P<0.01; Glu/Glu vs Glu/Lys+Lys/Lys: OR = 2.18, 95%CI:1.62-2.93, P<0.01). Subgroup analysis based on smoking suggested Exo1 K589E polymorphism conferred significant risk among smokers (Lys/Lys+Glu/Lys vs Glu/Glu: OR = 2.16, 95%CI:1.77-2.63, P<0.01), but not in non-smokers (Lys/Lys+Glu/Lys vs Glu/Glu: OR = 0.89, 95%CI:0.64-1.24, P = 0.50). In conclusion, Exo1 K589E Lys allele may be used as a novel biomarker for cancer susceptibility, particularly in smokers.Fujiao DuanChunhua SongLiping DaiShuli CuiXiaoqin ZhangXia ZhaoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 5, p e96764 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Fujiao Duan
Chunhua Song
Liping Dai
Shuli Cui
Xiaoqin Zhang
Xia Zhao
The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.
description The exonuclease1 (Exo1) gene is a key component of mismatch repair (MMR) by resecting the damaged strand, which is the only exonuclease involved in the human MMR system. The gene product is a member of the RAD2 nuclease family and functions in DNA replication, repair and recombination. However, whether Exo1 is required to activate MMR-dependent DNA damage response (DDR) remains unknown, the conclusions of the Exo1 polymorphisms on cancer susceptibility studies were not consistent. We carried out a meta-analysis of 7 case-control studies to clarify the association between the Exo1 K589E polymorphism and cancer risk. Overall,a significant association of the Exo1 K589E polymorphism with cancer risk in all genetic models (Lys vs Glu: OR = 1.51, 95%CI:1.39-1.99, P<0.01; Glu/Lys vs Glu/Glu: OR = 1.43, 95%CI:1.28-1.60, P<0.01; Lys/Lys vs Glu/Glu: OR = 2.45, 95%CI:1.90-3.17, P<0.01; Lys/Lys+Glu/Lys vs Glu/Glu: OR = 1.53, 95%CI:1.38-1.71, P<0.01; Glu/Glu vs Glu/Lys+Lys/Lys: OR =  2.27, 95%CI:1.79-2.89, P<0.01). In the stratified analysis by ethnicity, significantly increased risk was observed in Asian population (Lys vs Glu: OR = 1.53, 95%CI:1.39-1.69, P<0.01; Glu/Lys vs Glu/Glu: OR = 1.50, 95%CI:1.34-1.69, P<0.01; Lys/Lys vs Glu/Glu: OR = 2.48, 95%CI:1.84-3.34, P<0.01; Lys/Lys+Glu/Lys vs Glu/Glu: OR = 1.58, 95%CI:1.41-1.78, P<0.01; Glu/Glu vs Glu/Lys+Lys/Lys: OR = 2.18, 95%CI:1.62-2.93, P<0.01). Subgroup analysis based on smoking suggested Exo1 K589E polymorphism conferred significant risk among smokers (Lys/Lys+Glu/Lys vs Glu/Glu: OR = 2.16, 95%CI:1.77-2.63, P<0.01), but not in non-smokers (Lys/Lys+Glu/Lys vs Glu/Glu: OR = 0.89, 95%CI:0.64-1.24, P = 0.50). In conclusion, Exo1 K589E Lys allele may be used as a novel biomarker for cancer susceptibility, particularly in smokers.
format article
author Fujiao Duan
Chunhua Song
Liping Dai
Shuli Cui
Xiaoqin Zhang
Xia Zhao
author_facet Fujiao Duan
Chunhua Song
Liping Dai
Shuli Cui
Xiaoqin Zhang
Xia Zhao
author_sort Fujiao Duan
title The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.
title_short The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.
title_full The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.
title_fullStr The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.
title_full_unstemmed The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.
title_sort significance of exo1 k589e polymorphism on cancer susceptibility: evidence based on a meta-analysis.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/90c8213267b94292bea3d959ccd6721c
work_keys_str_mv AT fujiaoduan thesignificanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT chunhuasong thesignificanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT lipingdai thesignificanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT shulicui thesignificanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT xiaoqinzhang thesignificanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT xiazhao thesignificanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT fujiaoduan significanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT chunhuasong significanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT lipingdai significanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT shulicui significanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT xiaoqinzhang significanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
AT xiazhao significanceofexo1k589epolymorphismoncancersusceptibilityevidencebasedonametaanalysis
_version_ 1718421938505777152